Privia Health Group, Inc. (PRVA) vs Recursion Pharmaceuticals, Inc. (RXRX)
A side-by-side comparison of Privia Health Group, Inc. and Recursion Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
PRVA
Privia Health Group, Inc.
$20.46HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
RXRX
Recursion Pharmaceuticals, Inc.
$4.59HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
Total return — PRVA vs RXRX
growth of $100 · dividends reinvested · last 5yPRVA -11.1% (-2.3%/yr)RXRX -84.8% (-31.4%/yr)PRVA compounded faster over this window
Log scale — wide-divergence pair
PRVA RXRX
PRVA vs RXRX: by the numbers
- •PRVA is the larger company ($2.58B vs $2.41B market cap).
- •PRVA is profitable (1.19% net margin) while RXRX runs a net loss (-945.92%).
- •RXRX grew revenue faster over the past five years (45.50% vs 22.35% CAGR).
Metrics side by side
Valuation
| Metric | PRVA | RXRX |
|---|---|---|
| P/E ratio | 94.33 | N/A |
| Forward P/E | 79.44 | N/A |
| P/S ratio | 1.09 | 43.87 |
| P/B ratio | 0.00 | 2.63 |
Profitability
| Metric | PRVA | RXRX |
|---|---|---|
| Gross margin | 7.61% | -61.96% |
| Operating margin | 1.90% | -867.87% |
| Net margin | 1.19% | -945.92% |
| ROE | 0.00% | -56.71% |
| ROIC | 0.00% | -49.78% |
Growth (annualized)
| Metric | PRVA | RXRX |
|---|---|---|
| Revenue CAGR (5Y) | 22.35% | 45.50% |
| EPS CAGR (5Y) | -8.73% | N/A |
| Total return CAGR (5Y) | -1.30% | -25.86% |
Frequently asked
- Which has grown faster, PRVA or RXRX?
- Over the past five years, RXRX grew revenue faster — PRVA at a 22.35% CAGR versus RXRX at 45.50%.
- Is PRVA or RXRX more profitable?
- PRVA runs the higher net margin — PRVA at 1.19% versus RXRX at -945.92%.
- How have PRVA and RXRX total returns compared?
- Over the past 5 years, PRVA delivered -1.30% and RXRX delivered -25.86% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Privia Health P/E ratioPrivia Health ROERecursion Pharmaceuticals ROEPrivia Health operating marginRecursion Pharmaceuticals operating marginPrivia Health revenue growthRecursion Pharmaceuticals revenue growthPrivia Health free cash flowRecursion Pharmaceuticals free cash flow
Privia Health & Recursion Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.